is mounjaro a glp-1 receptor agonist Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), major breakthrough for the treatment of obesity PDB-101: Molecule of the Month:
Description
Additionally, research into novel delivery technologies, such as microneedle patches and implantable devices, holds the potential to further enhance patient convenience and compliance, thereby expanding the market reach and attractiveness of GLP-1 receptor agonists
The only way to know which alternative works best for your specific biology is systematic trial at therapeutic doses with adequate time for evaluation
2023;136(12):e2334
Nov 2023 - The FDA's approval of Eli Lillys Zepbound (tirzepatide) represents a significant advancement in obesity treatment, as it uniquely targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
Two classes of prescription medications frequently discussed are the GLP-1 receptor agonists (including Semaglutide, Ozempic, and Wegovy) and the stimulant phentermine
Peptide describes the type of molecule , not the quality of what youre being sold
